Table 3 Clinical characteristics
Variable | Frequency (%) |
|---|---|
CKD Stage | |
 1 | 12 (15.6) |
 2 | 22 (28.6) |
 3A | 15 (19.5) |
 3B | 20 (26.0) |
 4 | 8 (10.4) |
eGFRa Range: 25- > 90 M = 57.5 SD = 22.3 | |
Creatinine μmol/L Range: 48–259 M = 116.3 SD = 45.4 | |
Time Since Diagnosis (Self-Reported) Range: 4 months – 33 years Mdn = 5 years QR = 26.3–120.0 (months) | |
  ≤ 12 months | 11 (14.5) |
 12 years 1 month - 3 years | 13 (17.1) |
 3 years, 1 month - 5 years | 15 (19.7) |
 5 years, 1 month < 10 years | 12 (15.8) |
  ≥ 10 years | 25 (32.9) |
 Unknown | 2 (2.6) |
Cause of CKD | |
 Renovascular | 13 (16.9) |
 Glomerulonephritis | 13 (16.9) |
 Diabetes Mellitus (I or II) | 12 (15.6) |
 Systemic Lupus Erythematosus | 8 (10.4) |
 Other | 25 (32.5) |
 Unknown | 6 (7.8) |
Charlson Comorbidity Index Score Range: 2–11 Mdn = 5.5 IQR = 3.3–8.0 | |
 2–5 | 36 (50.0) |
 6–9 | 31 (43.1) |
 10+ | 5 (6.9) |
Smoking Status | |
 Non-smoker | 43 (55.1) |
 Ex-smoker | 28 (35.9) |
 Current Smoker | 7 (9.0) |
Current Medications Range: 1–14 Mdn: 6 | |